Improving Adherence to Medication in stroke Survivors (IAMSS)

a randomised controlled trial: study protocol

Ronan O'Carroll, Martin Dennis, Marie Johnston, Cathie Sudlow

Research output: Contribution to journalArticle

22 Citations (Scopus)
4 Downloads (Pure)

Abstract

Background
Adherence to therapies is a primary determinant of treatment success, yet the World Health Organisation estimate that only 50% of patients who suffer from chronic diseases adhere to treatment recommendations. In a previous project, we found that 30% of stroke patients reported sub-optimal medication adherence, and this was associated with younger age, greater cognitive impairment, lower perceptions of medication benefits and higher specific concerns about medication. We now wish to pilot a brief intervention aimed at (a) helping patients establish a better medication-taking routine, and (b) eliciting and modifying any erroneous beliefs regarding their medication and their stroke.

Methods/Design
Thirty patients will be allocated to a brief intervention (2 sessions) and 30 to treatment as usual. The primary outcome will be adherence measured over 3 months using Medication Event Monitoring System (MEMS) pill containers which electronically record openings. Secondary outcomes will include self reported adherence and blood pressure.

Discussion
This study shall also assess uptake/attrition, feasibility, ease of understanding and acceptability of this complex intervention.

Trial Registration
Current Controlled Trials ISRCTN38274953

Original languageEnglish
Article number15
Number of pages9
JournalBMC Neurology
Volume10
DOIs
Publication statusPublished - 24 Feb 2010

Fingerprint

Medication Adherence
Clinical Protocols
Survivors
Randomized Controlled Trials
Stroke
Therapeutics
Chronic Disease
Blood Pressure

Cite this

Improving Adherence to Medication in stroke Survivors (IAMSS) : a randomised controlled trial: study protocol. / O'Carroll, Ronan; Dennis, Martin; Johnston, Marie; Sudlow, Cathie.

In: BMC Neurology, Vol. 10, 15, 24.02.2010.

Research output: Contribution to journalArticle

@article{b08d6faa577646a082dbcb0c246cb1d1,
title = "Improving Adherence to Medication in stroke Survivors (IAMSS): a randomised controlled trial: study protocol",
abstract = "Background Adherence to therapies is a primary determinant of treatment success, yet the World Health Organisation estimate that only 50{\%} of patients who suffer from chronic diseases adhere to treatment recommendations. In a previous project, we found that 30{\%} of stroke patients reported sub-optimal medication adherence, and this was associated with younger age, greater cognitive impairment, lower perceptions of medication benefits and higher specific concerns about medication. We now wish to pilot a brief intervention aimed at (a) helping patients establish a better medication-taking routine, and (b) eliciting and modifying any erroneous beliefs regarding their medication and their stroke. Methods/Design Thirty patients will be allocated to a brief intervention (2 sessions) and 30 to treatment as usual. The primary outcome will be adherence measured over 3 months using Medication Event Monitoring System (MEMS) pill containers which electronically record openings. Secondary outcomes will include self reported adherence and blood pressure. Discussion This study shall also assess uptake/attrition, feasibility, ease of understanding and acceptability of this complex intervention. Trial Registration Current Controlled Trials ISRCTN38274953",
author = "Ronan O'Carroll and Martin Dennis and Marie Johnston and Cathie Sudlow",
year = "2010",
month = "2",
day = "24",
doi = "10.1186/1471-2377-10-15",
language = "English",
volume = "10",
journal = "BMC Neurology",
issn = "1471-2377",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Improving Adherence to Medication in stroke Survivors (IAMSS)

T2 - a randomised controlled trial: study protocol

AU - O'Carroll, Ronan

AU - Dennis, Martin

AU - Johnston, Marie

AU - Sudlow, Cathie

PY - 2010/2/24

Y1 - 2010/2/24

N2 - Background Adherence to therapies is a primary determinant of treatment success, yet the World Health Organisation estimate that only 50% of patients who suffer from chronic diseases adhere to treatment recommendations. In a previous project, we found that 30% of stroke patients reported sub-optimal medication adherence, and this was associated with younger age, greater cognitive impairment, lower perceptions of medication benefits and higher specific concerns about medication. We now wish to pilot a brief intervention aimed at (a) helping patients establish a better medication-taking routine, and (b) eliciting and modifying any erroneous beliefs regarding their medication and their stroke. Methods/Design Thirty patients will be allocated to a brief intervention (2 sessions) and 30 to treatment as usual. The primary outcome will be adherence measured over 3 months using Medication Event Monitoring System (MEMS) pill containers which electronically record openings. Secondary outcomes will include self reported adherence and blood pressure. Discussion This study shall also assess uptake/attrition, feasibility, ease of understanding and acceptability of this complex intervention. Trial Registration Current Controlled Trials ISRCTN38274953

AB - Background Adherence to therapies is a primary determinant of treatment success, yet the World Health Organisation estimate that only 50% of patients who suffer from chronic diseases adhere to treatment recommendations. In a previous project, we found that 30% of stroke patients reported sub-optimal medication adherence, and this was associated with younger age, greater cognitive impairment, lower perceptions of medication benefits and higher specific concerns about medication. We now wish to pilot a brief intervention aimed at (a) helping patients establish a better medication-taking routine, and (b) eliciting and modifying any erroneous beliefs regarding their medication and their stroke. Methods/Design Thirty patients will be allocated to a brief intervention (2 sessions) and 30 to treatment as usual. The primary outcome will be adherence measured over 3 months using Medication Event Monitoring System (MEMS) pill containers which electronically record openings. Secondary outcomes will include self reported adherence and blood pressure. Discussion This study shall also assess uptake/attrition, feasibility, ease of understanding and acceptability of this complex intervention. Trial Registration Current Controlled Trials ISRCTN38274953

U2 - 10.1186/1471-2377-10-15

DO - 10.1186/1471-2377-10-15

M3 - Article

VL - 10

JO - BMC Neurology

JF - BMC Neurology

SN - 1471-2377

M1 - 15

ER -